Neuropeptides
Volume 44, Issue 3 , Pages 215-224, June 2010

Pathogenic involvement of neuropeptides in anxiety and depression

Kansas City University of Medicine and Bioscience, College of Medicine, 1705 Independence Ave., Kansas City, United States

Received 14 August 2009; accepted 15 December 2009. published online 25 January 2010.

Abstract 

Anxiety and depression are highly prevalent disorders of mood posing significant challenges to individuals and society. Current evidence indicates no single neurobiological determinant underpins these conditions and an integrated approach in both research and treatment is expedient. Basic, behavioral, and clinical science indicates various stress-responsive neuropeptides in the neuroendocrine, autonomic, and behavioral pathophysiology of stress-related disorders including anxiety and depression. This review draws on recent research to capture the consensus and implications of neuropeptide research concerning the pathogenesis of anxiety and depression.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0143-4179(09)00153-X

doi:10.1016/j.npep.2009.12.014

Neuropeptides
Volume 44, Issue 3 , Pages 215-224, June 2010

Article Tools